Tailong Investment

Imbioray is a biotechnology company that specializes in cellular immunotherapy for tumors and immune diseases. The company engages in the development of global CAR-NK and tiNK cell therapy drugs and is committed to solving the treatment of clinically unmet diseases.

Mainstream Bio is a biotechnology company grounded in research, specializing in the development of innovative peptide therapeutics 2.0.

Yili Pharmaceutical is a pharmaceutical R&D company that mainly engages in biochemical product technology R&D, medical research and experimental development, engineering and technology research and experimental development, and software development.

C Ray Therapeutics develops healthcare advancements through nuclear medicine. It was founded in 2020.

XellSmart is a company based in Minhang District, Shanghai, China, focused on developing stem cell treatment solutions for various degenerative diseases that currently lack effective clinical treatments. The firm aims to enhance disease treatment and facilitate drug discovery through innovative stem cell therapies. XellSmart is dedicated to offering large-scale and cost-effective stem cell treatment, replacement, and transplantation options, specifically targeting major conditions like Parkinson's disease. By advancing these solutions, XellSmart seeks to provide patients with viable clinical alternatives to improve their health outcomes.

BiyoPharma focuses on the research and development of innovative drugs for neurological diseases, including episodic and chronic migraines, through international technology platforms and improved treatment options.

Yizun Biotechnology is a cutting-edge immune cell therapy company that has developed many unique platform technologies, including solid tumor treatment and allogeneic universal cell therapy.

LeadBio Tech is a biotechnology company focused on creating bioartificial blood vessel medical devices. The company specializes in tissue engineering and tissue regeneration solutions aimed at replacing and repairing human tissues and organs. LeadBio Tech develops degradable bioartificial blood vessels utilizing innovative skeleton immune wrapping technology. These products are primarily designed for use in arteriovenous graft surgeries, offering advanced artificial vessel solutions to enhance patient care and outcomes.

Cytocares is a research and development company specializing in the creation of innovative macromolecule drugs for tumor immunotherapy. The company focuses on developing novel medications aimed at enhancing tumor immunity, specifically targeting both hematological and solid tumors. By leveraging advanced drug design techniques, Cytocares provides potential treatments that could significantly improve patient outcomes in the fight against various forms of cancer.

Lab Direct is a developer of an online supply chain and procurement service platform, established in 2014 and headquartered in Shanghai, China. The platform facilitates direct connections between laboratories, research institutions, and suppliers, allowing users to access essential equipment and supplies efficiently. By streamlining the procurement process, Lab Direct enables laboratories to maintain a sufficient supply of necessary products, enhancing their operational capabilities and fostering partnerships within the research community.

Haixin zhihui is an artificial intelligence company. They offer intelligent diagnosis, and treatment systems for tumor diseases have been developed. They provide patients with precise treatment recommendations and assist patients in treatment planning and full disease management.